Mexico to start phase III clinical trials for China's Walvax COVID vaccine
MEXICO CITY, May 11 (Reuters) - Mexico plans to start phase III clinical trials for China's Walvax Biotechnology's 300142.SZ COVID-19 vaccine on May 30 and 6,000 volunteers are expected to participate, foreign minister Marcelo Ebrard said on Tuesday.
(Reporting by Anthony Esposito; Editing by Andrew Heavens)
((firstname.lastname@example.org; +5255 5282 7140;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.